Randal A. Byrn

5.4k total citations · 1 hit paper
49 papers, 4.0k citations indexed

About

Randal A. Byrn is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, Randal A. Byrn has authored 49 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Virology, 22 papers in Infectious Diseases and 17 papers in Immunology. Recurrent topics in Randal A. Byrn's work include HIV Research and Treatment (33 papers), HIV/AIDS drug development and treatment (19 papers) and Immune Cell Function and Interaction (13 papers). Randal A. Byrn is often cited by papers focused on HIV Research and Treatment (33 papers), HIV/AIDS drug development and treatment (19 papers) and Immune Cell Function and Interaction (13 papers). Randal A. Byrn collaborates with scholars based in United States, France and Sweden. Randal A. Byrn's co-authors include Jerome E. Groopman, David Baltimore, Timothy J. Gregory, Daniel J. Capon, Scot A. Marsters, Douglas H. Smith, Steven M. Chamow, JE Groopman, Kenji Ikeuchi and R. Alan B. Ezekowitz and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Randal A. Byrn

49 papers receiving 3.8k citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Designing CD4 immunoadhesins for AIDS therapy

1989 508 citations Daniel J. Capon, Steven M. Chamow et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Randal A. Byrn United States	27	2.3k	1.5k	1.4k	1.1k	944	49	4.0k
Stephen R. Petteway United States	25	3.1k 1.4×	1.4k 0.9×	2.1k 1.5×	1.6k 1.4×	1.1k 1.1×	47	4.8k
Daniel Zagury France	35	2.0k 0.9×	2.4k 1.5×	740 0.5×	885 0.8×	777 0.8×	144	4.2k
Timothy J. Gregory United States	26	2.6k 1.2×	1.7k 1.1×	1.2k 0.9×	1.1k 1.0×	957 1.0×	50	4.2k
Gerald Nakamura United States	30	1.8k 0.8×	1.2k 0.8×	817 0.6×	1.3k 1.2×	880 0.9×	45	3.6k
W A Haseltine United States	30	2.8k 1.3×	1.5k 1.0×	1.6k 1.2×	1.3k 1.2×	906 1.0×	47	4.4k
Robin A. Weiss United Kingdom	20	3.0k 1.3×	2.5k 1.6×	1.5k 1.1×	969 0.9×	920 1.0×	40	5.0k
Jesus F. Salazar-Gonzalez United States	20	3.9k 1.7×	2.1k 1.4×	2.0k 1.4×	1.0k 0.9×	1.1k 1.2×	36	5.1k
Lucia Lopalco Italy	36	2.5k 1.1×	2.0k 1.3×	1.2k 0.9×	737 0.7×	840 0.9×	116	4.0k
Kathelyn S. Steimer United States	29	2.2k 1.0×	1.4k 0.9×	1.1k 0.8×	950 0.9×	772 0.8×	53	3.4k
Éva Mária Fenyõ Sweden	38	3.5k 1.6×	1.9k 1.2×	2.2k 1.6×	741 0.7×	923 1.0×	116	4.6k

Countries citing papers authored by Randal A. Byrn

Since Specialization

Citations

This map shows the geographic impact of Randal A. Byrn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Randal A. Byrn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Randal A. Byrn more than expected).

Fields of papers citing papers by Randal A. Byrn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Randal A. Byrn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Randal A. Byrn. The network helps show where Randal A. Byrn may publish in the future.

Co-authorship network of co-authors of Randal A. Byrn

This figure shows the co-authorship network connecting the top 25 collaborators of Randal A. Byrn. A scholar is included among the top collaborators of Randal A. Byrn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Randal A. Byrn. Randal A. Byrn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Byrn, Randal A., Steven J.M. Jones, Michael P. Clark, et al.. (2014). Preclinical Activity of VX-787, a First-in-Class, Orally Bioavailable Inhibitor of the Influenza Virus Polymerase PB2 Subunit. Antimicrobial Agents and Chemotherapy. 59(3). 1569–1582. 149 indexed citations

Yamaguchi, Koushi & Randal A. Byrn. (1995). Clinical isolates of HIV-1 contain few pre-existing proteinase inhibitor resistance-conferring mutations. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 1253(2). 136–140. 15 indexed citations

Chamow, Steven M., Scot A. Marsters, David Peers, et al.. (1995). A Humanized, Bispecific Immunoadhesin-Antibody that Retargets CD3+ Effectors to Kill HIV-1-Infected Cells. Journal of Hematotherapy. 4(5). 439–446. 35 indexed citations

Kandimalla, Ekambar R., et al.. (1995). Design, biochemical, biophysical and biological properties of cooperative antisense oligonucleotides. Nucleic Acids Research. 23(17). 3578–3584. 20 indexed citations

Papp, Béla, et al.. (1994). Stimulation of Human Immunodeficiency Virus Type 1 Expression by Ceramide. AIDS Research and Human Retroviruses. 10(7). 775–780. 14 indexed citations

Yamaguchi, Koushi, Jerome E. Groopman, & Randal A. Byrn. (1994). The regulation of HIV by retinoic acid correlates with cellular expression of the retinoic acid receptors. AIDS. 8(12). 1675–1682. 32 indexed citations

Yamaguchi, Koushi, Zhengwen Zhang, & Randal A. Byrn. (1994). A Modified Nonradioactive Method for Northern Blot Analysis. Analytical Biochemistry. 218(2). 343–346. 5 indexed citations

Yamaguchi, Koushi, et al.. (1994). Fluorescent primers allow direct confirmation of restriction enzyme cleavage of PCR products.. PubMed. 17(4). 649–50, 652. 2 indexed citations

Berman, Phillip W., Donna J. Eastman, Gerald Nakamura, et al.. (1994). Comparison of the immune response to recombinant gp120 in humans and chimpanzees. AIDS. 8(5). 591–602. 25 indexed citations

10.

Byrn, Randal A., et al.. (1993). Neutralization of HIV-1 by F105, a human monoclonal antibody to the CD4 binding site of gp120.. PubMed. 6(1). 7–14. 122 indexed citations

11.

Nakamura, Gerald, Randal A. Byrn, Judith A. Fox, et al.. (1993). Strain specificity and binding affinity requirements of neutralizing monoclonal antibodies to the C4 domain of gp120 from human immunodeficiency virus type 1. Journal of Virology. 67(10). 6179–6191. 37 indexed citations

12.

Nakamura, Gerald, Randal A. Byrn, James P. Porter, et al.. (1992). Monoclonal Antibodies to the Extracellular Domain of HIV-1IIIB gp160 that Neutralize Infectivity, Block Binding to CD4, and React with Diverse Isolates. AIDS Research and Human Retroviruses. 8(11). 1875–1885. 26 indexed citations

13.

Chamow, Steven M., Anne‐Marie Duliège, A. J. Ammann, et al.. (1992). CD4 immunoadhesins in anti-HIV therapy: new developments.. PubMed. 7. 69–72. 7 indexed citations

14.

Posner, Marshall R., Teru Hideshima, Timothy Lewis Cannon, et al.. (1991). An IgG human monoclonal antibody that reacts with HIV-1/GP120, inhibits virus binding to cells, and neutralizes infection. The Journal of Immunology. 146(12). 4325–4332. 232 indexed citations

15.

Zeira, Michael, et al.. (1990). Inhibition of Serum-Enhanced HIV-1 Infection of U937 Monocytoid Cells by Recombinant Soluble CD4 and Anti-CD4 Monoclonal Antibody. AIDS Research and Human Retroviruses. 6(5). 629–639. 24 indexed citations

16.

Byrn, Randal A., Joyce Mordenti, Catherine Lucas, et al.. (1990). Biological properties of a CD4 immunoadhesin. Nature. 344(6267). 667–670. 140 indexed citations

17.

Kim, S, Kenji Ikeuchi, Randal A. Byrn, Jerome E. Groopman, & David Baltimore. (1989). Lack of a negative influence on viral growth by the nef gene of human immunodeficiency virus type 1.. Proceedings of the National Academy of Sciences. 86(23). 9544–9548. 235 indexed citations

18.

Capon, Daniel J., Steven M. Chamow, Joyce Mordenti, et al.. (1989). Designing CD4 immunoadhesins for AIDS therapy. Nature. 337(6207). 525–531. 508 indexed citations breakdown →

19.

Ikeuchi, Kenji, et al.. (1989). CD4+ lymphocyte function with early human immunodeficiency virus infection.. Proceedings of the National Academy of Sciences. 86(6). 1993–1997. 62 indexed citations

20.

Byrn, Randal A., et al.. (1985). Effect of heterogeneity of carcinoembryonic antigen on liver cell membrane binding and its kinetics of removal from circulation.. PubMed. 45(7). 3137–42. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact